Viewing Study NCT05422066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-02-20 @ 10:58 PM
Study NCT ID: NCT05422066
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2022-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma
Sponsor: Li Zhiming
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None DLBCL Germinal Center B-Cell Type View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Selinexor View
None Xpovio View
None Newly Diagnosed View
None DLBCL View
None IPI 3-5 View